Uyarılmış pluripotent kök hücreler (iPS) İlaç testi ve hücre replasman tedavileri için çok çeşitli hücre tiplerine ve dokulara dönüşme potansiyeline sahip. ancak, the “tarifler” for this conversion are often complicated and difficult to implement. Researchers at the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden, Harvard University (Amerika Birleşik Devletleri) and the University of Bonn have found a way to systematically extract hundreds of different cells quickly and easily from iPS using transcription factors, nöronlar dahil, connective tissue and blood vessel cells. Researchers can use this transcription factor source through the non-profit organization Addgene. The results have now been published in the journalNature Biotechnology.

The researchers used human induced pluripotent stem cells (iPS), which were reprogrammed from connective tissue cells into a quasi-embryonic state. In principle, iPS cells can be used to obtain all kinds of differentiated cells, from neurons to blood vessel cells, with each recipe being individually adapted. “Most differentiation protocols are very laborious and complicated. It’s not possible to obtain different cell types from iPS simultaneously and in a controlled manner in a single culture,” explains Prof. Dr. Volker Busskamp, who works at the Eye Clinic and the ImmunoSensation2 Cluster of Excellence at the University of Bonn the Excellence Cluster Physics of Life (PoL) and at the CRTD at TU Dresden.

Together with a team from Harvard University, TU Dresden and the University of Bonn, he aimed to replace the complicated procedures with simplerecipes.Using a large-scale screening process, the researchers found a total of 290 DNA-binding proteins that quickly and efficiently reprogram stem cells into target cells. The researchers were able to demonstrate that just a single transcription factor is sufficient in each case to derive differentiated neurons, bağ dokusu, blood vessel and glial cells from the stem cells within four days. The latter coat neurons asinsulators.

A genetic switchboard for stem cell differentiation

Using automated procedures, the researchers introduced the DNA sequence for the respective transcription factor and other control elements into the stem cell genome. The transcription factors could be activated by adding a small molecule, causing some of the transgenic stem cells to be converted into differentiated cells. It was then possible to distinguish and automatically sort stem cells and differentiated cells using cell markers. The researchers subsequently investigated how much of a certain transcription factor was present in the differentiated cells compared to the stem cells. “The greater the difference, the more important the respective transcription factor seems to be for the conversion of iPS into differentiated cells,” explains Busskamp.

The team used this method to test a total of 1732 potential transcription factors on three different stem cell lines. The researchers found an effect for 290 different transcription factors that caused the iPS to convert into differentiated cells. This is new territory, because this property of the iPS programming of 241 of the discovered transcription factors was previously unknown. Using the example of neurons, bağ dokusu, blood vessel and glial cells, the researchers performed various tests to show that the converted cells are very similar to human body cells in their functional ability.

The results open new possibilities in research

“Tanımlanan transkripsiyon faktörlerinin avantajı, iPS'yi özellikle hızlı ve kolay bir şekilde vücut hücrelerine dönüştürebilmeleri ve potansiyel olarak daha karmaşık dokular oluşturmak için de kullanılabilmeleridir.,” diyor Busskamp. Haftalar, hatta aylar süren şey artık günler içinde oluyor. Maliyetli ve zaman alan protokoller yerine, toplu taramada tespit edilen isabetler için tek bir transkripsiyon faktörü yeterlidir.

Kategoriler: Hücreler terapi Kök


Kontrat Araştırma Organizasyonu

Kök hücre tedavisi